We then analyzed IFNγ-producing T cells in the spleen and found that the percentage of IFNγ-producing CD4 T cells in APP+/+ or APP−/− mESC-TEP-transplanted AD mice was significantly higher than that in control cell-treated mice (Figures 4E,F). This evidence concerns the gene IFNG and Alzheimer disease.